Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
BridgeBio Pharma Inc.
Director
BridgeBio Oncology Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Oct 29, 2025 | BridgeBio Pharma Inc. | Open-market sale | −111,755 | $65.48 | $7,317,717 |
| Oct 29, 2025 | BridgeBio Pharma Inc. | Open-market sale | −31,116 | $66.20 | $2,059,879 |
| Oct 29, 2025 | BridgeBio Pharma Inc. | Open-market sale | −3,497 | $67.52 | $236,117 |
| Oct 29, 2025 | BridgeBio Pharma Inc. | Open-market sale | −8,598 | $68.50 | $588,963 |
| Oct 29, 2025 | BridgeBio Pharma Inc. | Open-market sale | −43,393 | $69.24 | $3,004,531 |
| Oct 27, 2025 | BridgeBio Pharma Inc. | Open-market sale | −1,641 | $65.00 | $106,665 |
| Sep 5, 2025 | BridgeBio Pharma Inc. | Option exercise | +74,000 | $11.92 | $882,080 |
| Sep 5, 2025 | BridgeBio Pharma Inc. | Open-market sale | −74,000 | $53.16 | $3,933,840 |
| Jun 24, 2025 | BridgeBio Pharma Inc. | Open-market sale | −100,000 | $44.23 | $4,423,000 |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| May 8, 2025 | BridgeBio Pharma Inc. | Gift | −3,000 | — | — |
| May 7, 2025 | BridgeBio Pharma Inc. | Gift | −33,000 | — | — |
| Dec 26, 2024 | BridgeBio Pharma Inc. | Gift | −7,400 | — | — |
| Dec 26, 2023 | BridgeBio Pharma Inc. | Open-market sale | −100,000 | $42.06 | $4,206,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.